Reversible Cerebral Vasoconstriciton Syndrome
www.UptoDate.com, June, Singhal, A., 2019
Moyamoya Disease Presenting with Subarachnoid Hemorrhage: Clinical Features and Neuroimaging of a Case Series
Brit J Neurosurg 29:804-810, Wan, M.,et al, 2015
Variable Presentations of Postpartum Angiopathy
Stroke 43:670-676, Fugate,J.E.,et al, 2012
Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome: Frequency, Features, and Risk Factors
Stroke 41:2505-2511, 2455, Ducros,A.,et al, 2010
Reversible Cerebral Vasoconstriction Syndrome
Pract Neurol 9:256-267, Ducros,A. &Bousser,M.-G., 2009
Thrombosis of the Straight Sinus Complicating Hormone Replacement Therapy
Br J Neurosurg 9:805-808, Strachan, R. & Hughes, D., 2008
The Clinical and Radiological Spectrum of Reversible Cerebral Vasoconstriction Syndrome. A Prospective Series of 67 Patients
Brain 130:3091-3101, Ducros, A.,et al, 2007
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Phenylpropanolamine and Hemorrhagic Stroke
NEJM 344:1094-1095, Ernst,M.E.,et al, 2001
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
NEJM 343:1826-1832,1886, Kernan,W.N.,et al, 2000
Aspirin Use and Incident Stroke in the Cardiovascular Health Study
Stroke 29:887-894, 8851998., Kronmal,R.A.,et al, 1998